Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
Targeting Esophageal Cancer: Promising Drugs for the Clinical Landscape and Key Knowledge Gaps.
Journal: Drug design, development and therapy
Published: September 27, 2025
Phase I study of allogeneic monocyte-derived inflammatory dendritic cells in combination with pembrolizumab.
Journal: Future science OA
Published: November 20, 2024
The preclinical discovery and development of zolbetuximab for the treatment of gastric cancer.
Journal: Expert opinion on drug discovery
Published: June 26, 2024
Stimulating Soluble Guanylyl Cyclase with the Clinical Agonist Riociguat Restrains the Development and Progression of Castration-Resistant Prostate Cancer.
Journal: Cancer research
Published: January 11, 2024
Correction: Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: a Phase I Dose Escalation and Expansion Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 14, 2023
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer.
Journal: NPJ precision oncology
Published: October 06, 2023
The soluble guanylyl cyclase pathway is inhibited to evade androgen deprivation-induced senescence and enable progression to castration resistance.
Journal: bioRxiv : the preprint server for biology
Published: May 19, 2023
T cell-inflamed gene expression profile and PD-L1 expression and pembrolizumab efficacy in advanced esophageal cancer.
Journal: Future oncology (London, England)
Published: July 19, 2022
An overview of the preclinical discovery and development of trastuzumab deruxtecan: a novel gastric cancer therapeutic.
Journal: Expert opinion on drug discovery
Published: April 15, 2022
Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 02, 2022
Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 01, 2021
Last Updated: 09/26/2026